Persistent
Burkholderia pseudomallei
ceftazidime
melioidosis
persistent bacteremia
resistance
Journal
Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042
Informations de publication
Date de publication:
28 Jan 2019
28 Jan 2019
Historique:
received:
31
12
2018
revised:
20
01
2019
accepted:
26
01
2019
entrez:
31
1
2019
pubmed:
31
1
2019
medline:
31
1
2019
Statut:
epublish
Résumé
Melioidosis is rare in the United States and endemic to Southeast Asia and Australia. Treatment includes an initial intensive phase of intravenous ceftazidime or meropenem monotherapy depending on severity. The following report describes a case of persistent bacteremia with ceftazidime failure and prolonged meropenem therapy on a ceftazidime-susceptible strain of
Identifiants
pubmed: 30696064
pii: tropicalmed4010020
doi: 10.3390/tropicalmed4010020
pmc: PMC6473904
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Clin Infect Dis. 1999 Aug;29(2):381-7
pubmed: 10476746
Antimicrob Agents Chemother. 2004 May;48(5):1763-5
pubmed: 15105132
Clin Infect Dis. 2007 Aug 15;45(4):521-3
pubmed: 17638209
Am J Trop Med Hyg. 2011 Jun;84(6):858-61
pubmed: 21633019
J Glob Infect Dis. 2011 Apr;3(2):183-6
pubmed: 21731307
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17165-70
pubmed: 21969582
Emerg Infect Dis. 2012 Dec;18(12):e2
pubmed: 23171644
Int J Antimicrob Agents. 2014 Apr;43(4):310-8
pubmed: 24613038
Semin Respir Crit Care Med. 2015 Feb;36(1):111-25
pubmed: 25643275
Lancet. 1989 Sep 23;2(8665):697-701
pubmed: 2570956
PLoS Negl Trop Dis. 2015 Mar 26;9(3):e0003586
pubmed: 25811783
Emerg Infect Dis. 2015 Oct;21(10):1884-5
pubmed: 26401597
BMC Infect Dis. 2016 Jul 16;16:333
pubmed: 27423906